NCT00802477 - Application Of Autologous Blood Products During Modified Radical Mastectomy | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

March 31, 2012

Conditions

Mastectomy

Interventions

PROCEDURE

Application of autologous blood products.

Autologous blood products (platelet rich and platelet poor plasma) produced by the PlasmaxTM Plus Plasma Concentration System will be applied to the surgical site.

PROCEDURE

Standard Modified Radical Mastectomy

Mastectomy per standard procedure without the application of autologous blood products.

Trial Locations (1)

25701

RECRUITING

University Oncology Services at Edwards Comprehensive Cancer Center, Huntington